BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21649453)

  • 1. EDTA redistribution of lead and cadmium into the soft tissues in a human with a high lead burden - should DMSA always be used to follow EDTA in such cases?
    Crinnion WJ
    Altern Med Rev; 2011 Jun; 16(2):109-12. PubMed ID: 21649453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
    Bradberry S; Sheehan T; Vale A
    QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites.
    Lee BK; Schwartz BS; Stewart W; Ahn KD
    Occup Environ Med; 1995 Jan; 52(1):13-9. PubMed ID: 7697134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
    Cory-Slechta DA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Succimer treatment and calcium supplementation reduce tissue lead in suckling rats.
    Marija Varnai V; Piasek M; Blanusa M; Matek Sarić M; Juresa D; Kostial K
    J Appl Toxicol; 2004; 24(2):123-8. PubMed ID: 15052607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic occupational lead poisoning with dimercaptosuccinic acid (DMSA)].
    Grandjean P; Jacobsen IA; Jørgensen PJ; Lings S; Andersen O
    Ugeskr Laeger; 1991 Oct; 153(41):2897-9. PubMed ID: 1659012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning.
    Sánchez-Fructuoso AI; Cano M; Arroyo M; Fernández C; Prats D; Barrientos A
    Am J Kidney Dis; 2002 Jul; 40(1):51-8. PubMed ID: 12087561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial role of monoesters of meso-2,3-dimercaptosuccinic acid in the mobilization of lead and recovery of tissue oxidative injury in rats.
    Saxena G; Pathak U; Flora SJ
    Toxicology; 2005 Oct; 214(1-2):39-56. PubMed ID: 16019123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of calcium disodium EDTA and meso-2,3-dimercaptosuccinic acid on tissue concentrations of lead for use in treatment of calves with experimentally induced lead toxicosis.
    Meldrum JB; Ko KW
    Am J Vet Res; 2003 Jun; 64(6):672-6. PubMed ID: 12828250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
    Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelation of lead during co-exposure to ethanol.
    Dhawan M; Flora SJ; Singh S; Tandon SK
    Biochem Int; 1989 Nov; 19(5):1067-75. PubMed ID: 2561440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potentials of combined use of DMSA with calcium and ascorbic acid in the treatment of mild to moderately lead intoxicated mice.
    Liao Y; Zhang J; Jin Y; Lu C; Li G; Yu F; Zhi X; An L; Yang J
    Biometals; 2008 Feb; 21(1):1-8. PubMed ID: 17287888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
    Besunder JB; Anderson RL; Super DM
    Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in brain biogenic amines and haem biosynthesis and their response to combined administration of succimers and Centella asiatica in lead poisoned rats.
    Saxena G; Flora SJ
    J Pharm Pharmacol; 2006 Apr; 58(4):547-59. PubMed ID: 16597373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rac- and meso-2,3-dimercaptosuccinic acids for chelation of mercury and cadmium using chemical speciation models.
    Fang X; Hua F; Fernando Q
    Chem Res Toxicol; 1996; 9(1):284-90. PubMed ID: 8924605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children.
    Chisolm JJ
    J Toxicol Clin Toxicol; 1992; 30(4):493-504. PubMed ID: 1331490
    [No Abstract]   [Full Text] [Related]  

  • 18. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ; Pande M; Kannan GM; Mehta A
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of zinc supplementation during chelation treatment of lead intoxication in rats.
    Flora SJ; Tandon SK
    Toxicology; 1990 Nov; 64(2):129-39. PubMed ID: 2171159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.